Senolytic and senomorphic therapies are advancing with compounds like RLS-1496 and α-ESA-me targeting senescent cells. Experts highlight challenges in biomarkers and safety, pushing for personalized ...
Zhang et al. (2026) discovered that α-eleostearic acid and its methyl ester act as novel senolytic agents by inducing ferroptosis in senescent cells, achieving over 80% clearance with minimal toxicit...
Aging research is pivoting from lifespan extension to enhancing healthspan, with innovations like senolytic drugs and digital health tools transforming clinical practices. Recent geroscience advances ...
Recent studies reveal that supplementing Roseburia inulinivorans enhances muscle strength by up to 30% in mice, with human trials showing promise for probiotic therapies against sarcopenia. New resear...
Emerging research shows that enhancing mRNA surveillance mechanisms like nonsense-mediated decay can reduce neurodegeneration, with innovative therapies targeting tau aggregation offering new hope. Re...
Recent studies reveal aging microglia can promote amyloid-β aggregation, shifting Alzheimer’s pathology understanding and highlighting new therapeutic strategies targeting immune-brain interact...
Recent research identifies specific senescent cell types linked to diabetes and hypertension, enabling personalized therapies and AI-driven predictive health tools for aging populations. New studies m...
The cGAS-STING pathway, crucial for innate immunity, drives harmful neuroinflammation in aging and Alzheimer’s, with recent studies highlighting therapeutic challenges and biomarker potential fo...
An analysis of clonal hematopoiesis, a somatic mosaicism in blood cells linked to aging, cancer, and cardiovascular risks, exploring ethical challenges in screening. Recent studies highlight clonal he...
Recent studies validate blood biomarkers like p-tau217 for predicting Alzheimer’s onset within 3-4 years at 94% accuracy, enabling early interventions but raising ethical and socioeconomic conce...